Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PB127 MCE vs Stress SPECT in Suspected Obstructive CAD
NCT00595244Phase 3Completed
- Sponsor
- POINT Biomedical
- Start
- Jul 2002
- Primary completion
- Oct 2003
- Countries
- 1
01
Overview
A Phase 3 trial of PB127 in coronary artery disease (CAD), sponsored by POINT Biomedical. Started Jul 2002; status: completed.
02
Drugs
PB127
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00595244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00595244.